Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin Metabolism as a Test for Celiac Disease Activity
NCT03011931Phase 1Completed
- Sponsor
- Entero Therapeutics, Inc.
- Start
- Mar 2016
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of simvastatin in celiac disease, sponsored by Entero Therapeutics, Inc. Primary endpoint: Compare simvastatin metabolism with intestinal biopsies at 1 month. Started Mar 2016; status: completed.
02
Drugs
simvastatin
03
Conditions
celiac disease
Beyond the preview
Go deeper on NCT03011931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03011931.